About Us

Enabling a new era of personalized medicine.

Cynvenio Biosystems, Inc. is a California biotech company dedicated to providing game-changing technology to improve the diagnosis and treatment of cancer patients.

Cynvenio’s rare cell detection and mutational profiling applications include the LiquidBiopsy™ blood test for the early detection of cancer, and the selection of individual patient therapeutic solutions.

Cynvenio Biosystems, Inc. was launched in 2007 on the strength of foundational technology developed at the University of California, Santa Barbara. The company’s R&D and principal operations are based in Westlake Village, California (Los Angeles). The company is privately funded.

At Cynvenio we are dedicated to enabling the new era of personalized medicine for all cancer patients.